» Articles » PMID: 22137893

Hydroxynonenal-generated Crosslinking Fluorophore Accumulation in Alzheimer Disease Reveals a Dichotomy of Protein Turnover

Abstract

Lipid peroxidation generates reactive aldehydes, most notably hydroxynonenal (HNE), which covalently bind amino acid residue side chains leading to protein inactivation and insolubility. Specific adducts of lipid peroxidation have been demonstrated in intimate association with the pathological lesions of Alzheimer disease (AD), suggesting that oxidative stress is a major component of AD pathogenesis. Some HNE-protein products result in protein crosslinking through a fluorescent compound similar to lipofuscin, linking lipid peroxidation and the lipofuscin accumulation that commonly occurs in post-mitotic cells such as neurons. In this study, brain tissue from AD and control patients was examined by immunocytochemistry and immunoelectron microscopy for evidence of HNE-crosslinking modifications of the type that should accumulate in the lipofuscin pathway. Strong labeling of granulovacuolar degeneration (GVD) and Hirano bodies was noted but lipofuscin did not contain this specific HNE-fluorophore. These findings directly implicate lipid crosslinking peroxidation products as accumulating not in the lesions or the lipofuscin pathways, but instead in a distinct pathway, GVD, that accumulates cytosolic proteins.

Citing Articles

Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies.

Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J Front Immunol. 2025; 15:1484373.

PMID: 39877373 PMC: 11772192. DOI: 10.3389/fimmu.2024.1484373.


ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer's disease.

Ramsden C, Zamora D, Horowitz M, Jahanipour J, Calzada E, Li X Acta Neuropathol Commun. 2023; 11(1):197.

PMID: 38093390 PMC: 10720169. DOI: 10.1186/s40478-023-01693-9.


Role of Nanoparticle-Conjugates and Nanotheranostics in Abrogating Oxidative Stress and Ameliorating Neuroinflammation.

Patel T, Kevadiya B, Bajwa N, Singh P, Zheng H, Kirabo A Antioxidants (Basel). 2023; 12(10).

PMID: 37891956 PMC: 10604131. DOI: 10.3390/antiox12101877.


Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer's Disease.

Obis E, Sol J, Andres-Benito P, Martin-Gari M, Mota-Martorell N, Galo-Licona J Aging Dis. 2023; 14(5):1887-1916.

PMID: 37196109 PMC: 10529741. DOI: 10.14336/AD.2023.0217.


Mitochondrial dynamics in neurological diseases: a narrative review.

Shen Y, Jiang W, Li X, Cao A, Li D, Li S Ann Transl Med. 2023; 11(6):264.

PMID: 37082676 PMC: 10113088. DOI: 10.21037/atm-22-2401.


References
1.
Smith M, Taneda S, Richey P, Miyata S, Yan S, Stern D . Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A. 1994; 91(12):5710-4. PMC: 44066. DOI: 10.1073/pnas.91.12.5710. View

2.
Monagle R, Brody H . The effects of age upon the main nucleus of the inferior olive in the human. J Comp Neurol. 1974; 155(1):61-6. DOI: 10.1002/cne.901550105. View

3.
Funk K, Mrak R, Kuret J . Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol. 2010; 37(3):295-306. PMC: 3037976. DOI: 10.1111/j.1365-2990.2010.01135.x. View

4.
Moreira P, Siedlak S, Wang X, Santos M, Oliveira C, Tabaton M . Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 2007; 3(6):614-5. DOI: 10.4161/auto.4872. View

5.
Moreira P, Siedlak S, Wang X, Santos M, Oliveira C, Tabaton M . Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol. 2007; 66(6):525-32. DOI: 10.1097/01.jnen.0000240476.73532.b0. View